CHAPTER 1. Industry Overview of Androgenetic Alopecia Market
1.1. Definition and Scope
1.1.1. Definition of Androgenetic Alopecia
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Androgenetic Alopecia Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Androgenetic Alopecia Market By Gender
1.2.3. Androgenetic Alopecia Market By Treatment
1.2.4. Androgenetic Alopecia Market By End-use
1.2.5. Androgenetic Alopecia Market By Sales Channel
1.2.6. Androgenetic Alopecia Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Androgenetic Alopecia Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Androgenetic Alopecia Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Androgenetic Alopecia Market By Gender
5.1. Introduction
5.2. Androgenetic Alopecia Revenue By Gender
5.2.1. Androgenetic Alopecia Revenue (USD Billion) and Forecast, By Gender, 2020-2032
5.2.2. Female
5.2.2.1. Female Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Male
5.2.3.1. Male Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Androgenetic Alopecia Market By Treatment
6.1. Introduction
6.2. Androgenetic Alopecia Revenue By Treatment
6.2.1. Androgenetic Alopecia Revenue (USD Billion) and Forecast, By Treatment, 2020-2032
6.2.2. Devices
6.2.2.1. Devices Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Pharmaceuticals
6.2.3.1. Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Androgenetic Alopecia Market By End-use
7.1. Introduction
7.2. Androgenetic Alopecia Revenue By End-use
7.2.1. Androgenetic Alopecia Revenue (USD Billion) and Forecast, By End-use, 2020-2032
7.2.2. Homecare Settings
7.2.2.1. Homecare Settings Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Dermatology Clinics
7.2.3.1. Dermatology Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Androgenetic Alopecia Market By Sales Channel
8.1. Introduction
8.2. Androgenetic Alopecia Revenue By Sales Channel
8.2.1. Androgenetic Alopecia Revenue (USD Billion) and Forecast, By Sales Channel, 2020-2032
8.2.2. OTC
8.2.2.1. OTC Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Prescriptions
8.2.3.1. Prescriptions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Androgenetic Alopecia Market By Country
9.1. North America Androgenetic Alopecia Market Overview
9.2. U.S.
9.2.1. U.S. Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
9.2.2. U.S. Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
9.2.3. U.S. Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.2.4. U.S. Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
9.3. Canada
9.3.1. Canada Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
9.3.2. Canada Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
9.3.3. Canada Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.3.4. Canada Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Androgenetic Alopecia Market By Country
10.1. Europe Androgenetic Alopecia Market Overview
10.2. U.K.
10.2.1. U.K. Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
10.2.2. U.K. Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
10.2.3. U.K. Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.2.4. U.K. Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
10.3. Germany
10.3.1. Germany Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
10.3.2. Germany Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
10.3.3. Germany Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.3.4. Germany Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
10.4. France
10.4.1. France Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
10.4.2. France Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
10.4.3. France Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.4.4. France Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
10.5. Spain
10.5.1. Spain Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
10.5.2. Spain Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
10.5.3. Spain Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.5.4. Spain Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
10.6.2. Rest of Europe Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
10.6.3. Rest of Europe Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.6.4. Rest of Europe Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Androgenetic Alopecia Market By Country
11.1. Asia Pacific Androgenetic Alopecia Market Overview
11.2. China
11.2.1. China Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
11.2.2. China Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
11.2.3. China Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.2.4. China Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
11.3. Japan
11.3.1. Japan Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
11.3.2. Japan Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
11.3.3. Japan Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.3.4. Japan Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
11.4. India
11.4.1. India Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
11.4.2. India Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
11.4.3. India Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.4.4. India Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
11.5. Australia
11.5.1. Australia Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
11.5.2. Australia Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
11.5.3. Australia Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.5.4. Australia Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
11.6. South Korea
11.6.1. South Korea Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
11.6.2. South Korea Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
11.6.3. South Korea Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.6.4. South Korea Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
11.7.2. Rest of Asia-Pacific Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
11.7.3. Rest of Asia-Pacific Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.7.4. Rest of Asia-Pacific Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Androgenetic Alopecia Market By Country
12.1. Latin America Androgenetic Alopecia Market Overview
12.2. Brazil
12.2.1. Brazil Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
12.2.2. Brazil Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
12.2.3. Brazil Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.2.4. Brazil Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
12.3. Mexico
12.3.1. Mexico Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
12.3.2. Mexico Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
12.3.3. Mexico Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.3.4. Mexico Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
12.4.2. Rest of Latin America Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
12.4.3. Rest of Latin America Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.4.4. Rest of Latin America Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Androgenetic Alopecia Market By Country
13.1. Middle East & Africa Androgenetic Alopecia Market Overview
13.2. GCC
13.2.1. GCC Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
13.2.2. GCC Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
13.2.3. GCC Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.2.4. GCC Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
13.3. South Africa
13.3.1. South Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
13.3.2. South Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
13.3.3. South Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.3.4. South Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By Gender, 2020-2032
13.4.2. Rest of Middle East & Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By Treatment, 2020-2032
13.4.3. Rest of Middle East & Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.4.4. Rest of Middle East & Africa Androgenetic Alopecia Revenue (USD Billion) and Forecast By Sales Channel, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Androgenetic Alopecia Market
14.1. Androgenetic Alopecia Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Androgenetic Alopecia Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Johnson & Johnson Services, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Johnson & Johnson Services, Inc. 2022 Androgenetic Alopecia Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Sun Pharmaceutical Industries Ltd.
15.3. Cipla, Inc.
15.4. Theradome Inc.
15.5. Merck & Co., Inc.
15.6. Aurobindo Pharma
15.7. Dr. Reddy’s Laboratories Ltd.
15.8. Apira Science, Inc.
15.9. Lexington Intl., LLC
15.10. Curallux, LLC
15.11. Freedom Laser Therapy, Inc.
The androgenetic alopecia market size was USD 2.4 Billion in 2022.
The CAGR of androgenetic alopecia is 7.9% during the analysis period of 2023 to 2032.
The key players operating in the global market are including Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., Cipla, Inc., Theradome Inc., Merck & Co., Inc., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., Apira Science, Inc., Lexington Intl., LLC, Curallux, LLC, and Freedom Laser Therapy, Inc.
North America held the dominating position in androgenetic alopecia industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of androgenetic alopecia during the analysis period of 2023 to 2032.
The current trends and dynamics in the androgenetic alopecia industry include increasing prevalence of androgenetic alopecia due to aging demographics, and continuous innovation in treatment options, including topical formulations and surgical techniques.
The pharmaceuticals treatment held the maximum share of the androgenetic alopecia industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date